$REGN Form 8-K

0
451

Form 8-K for REGENERON PHARMACEUTICALS INC


9-Feb-2017

Results of Operations and Financial Condition, Financial Statements

Item 2.02 Results of Operations and Financial Condition.On February 9, 2017, Regeneron Pharmaceuticals, Inc. issued a press release announcing its financial and operating results for the quarter and year ended December 31, 2016. A copy of the press release is being furnished to the Securities and Exchange Commission as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference to this Item 2.02.

The information included or incorporated in this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall such information and exhibit be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

 

Item 9.01 Financial Statements and Exhibits.(d) Exhibits

99.1 Press Release, dated February 9, 2017, Reporting Fourth Quarter and Full Year 2016 Financial and Operating Results.

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here